Malignant melanoma with metaplastic cartilaginous transdifferentiation: A case report

dc.contributor.authorBerro, Juliett
dc.contributor.authorAbdul Halim, Nour
dc.contributor.authorKhaled, Chirine S.
dc.contributor.authorAssi, Hazem I.
dc.contributor.departmentInternal Medicine
dc.contributor.departmentPathology and Laboratory Medicine
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:54:14Z
dc.date.available2025-01-24T11:54:14Z
dc.date.issued2019
dc.description.abstractMalignant melanoma is notorious for its remarkable morphological variation and aberrant histopathological patterns. However, melanoma with prominent cartilaginous transdifferentiation simulating chondrosarcoma is extremely rare. A 75-year-old male developed a swelling in his left inguinal region and was diagnosed with a metastatic melanoma, which was found to harbor a BRAF V600E mutation. Later on, the left inguinal lymph node was excised and immunohistochemistry done on the specimen revealed an undifferentiated component negative for S-100 protein, HMB-45 and Melan-A and a cartilaginous component positive for S-100 protein and diffusely positive for BRAF V600E mutation. To our knowledge, there are around 14 cases reported in the literature of malignant melanoma with pure cartilaginous transdifferentiation. In all cases, immunohistochemistry of the cartilaginous component was positive for S-100, which is not an indicator of melanoma because cartilage expresses S-100. BRAF mutational studies support that the tumor arose from a common melanoma cell that harbored the mutation and subsequently transdifferentiated. This case illustrates the importance of an accurate and thorough clinical assessment when it comes to the diagnosis of melanomas as they are notable for their impressive degree of morphologic variability. Moreover, this report helps shed light on the use of immunohistochemical analysis to reach a definitive diagnosis. © 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
dc.identifier.doihttps://doi.org/10.1111/cup.13539
dc.identifier.eid2-s2.0-85070078463
dc.identifier.pmid31260118
dc.identifier.urihttp://hdl.handle.net/10938/31148
dc.language.isoen
dc.publisherBlackwell Publishing Ltd
dc.relation.ispartofJournal of Cutaneous Pathology
dc.sourceScopus
dc.subjectBraf
dc.subjectCartilaginous transdifferentiation
dc.subjectMelanoma
dc.subjectS-100
dc.subjectAged
dc.subjectCartilage diseases
dc.subjectCell transdifferentiation
dc.subjectFatal outcome
dc.subjectHumans
dc.subjectImmunohistochemistry
dc.subjectLymph nodes
dc.subjectLymphatic metastasis
dc.subjectMale
dc.subjectMap kinase kinase 1
dc.subjectMetaplasia
dc.subjectMutation
dc.subjectProtein kinase inhibitors
dc.subjectProto-oncogene proteins b-raf
dc.subjectS100 proteins
dc.subjectB raf kinase
dc.subjectBraf protein, human
dc.subjectMitogen activated protein kinase kinase 1
dc.subjectProtein kinase inhibitor
dc.subjectProtein s 100
dc.subjectCase report
dc.subjectChondropathy
dc.subjectFatality
dc.subjectGenetics
dc.subjectHuman
dc.subjectImmunology
dc.subjectLymph node
dc.subjectLymph node metastasis
dc.subjectMetabolism
dc.subjectPathology
dc.titleMalignant melanoma with metaplastic cartilaginous transdifferentiation: A case report
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2019-3673.pdf
Size:
4.58 MB
Format:
Adobe Portable Document Format